New antitoxin aims to speed kidney recovery in kids with e. coli infection
Disease control
Recruiting now
This study tests a new medicine called INM004 in 220 children with hemolytic uremic syndrome (HUS) caused by E. coli bacteria. The goal is to see if it helps the kidneys recover faster and reduces the need for dialysis. Participants are children aged 9 months to 18 years who have…
Phase: PHASE3 • Sponsor: Inmunova S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC